Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells

Leukemia

Volumn 15, Issue 5, 2001, Pages 794-807

  Blalock, W L ^a   Pearce, M ^a   Chang, F ^a   Lee, J T ^a   Pohnert, S C ^a   Burrows, C ^a   Steelman, L S ^a   Franklin, R A ^a   McMahon, M ^b   McCubrey, J A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cytokines; MEK1; Oncogenes; Signal transduction

Indexed keywords

4 HYDROXYTAMOXIFEN; CELL SURFACE RECEPTOR; CYTOKINE; ESTRADIOL; ESTROGEN RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; HYBRID PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; RECEPTOR BLOCKING AGENT; RECEPTOR SUBUNIT; THYMIDINE; TRITIUM;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BETA CHAIN; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HEMATOPOIETIC CELL; LYMPHOID CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION;

EID: 0035019189     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402109     Document Type: Article

References (65)

1. Cytokines: Coordinators of immune and inflammatory responses
2. Regulation of interleukin-3 expression in normal and autocrine transformed hematopoietic cells
3. Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: Possible sites for intervention with anti-neoplastic drugs
4. Growth of factor-dependent hematopoietic precursor cell lines
5. Enrichment of hematopoietic precursor cells and cloning of B-lymphocyte precursors
6. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin
7. Abrogation of factor-dependence in two IL-3-dependent cell lines can occur by two distinct mechanisms
8. Differential abilities of activated Raf oncoproteins to abrogate cytokine-dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells
9. Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogene
10. Phorbol esters support the proliferation of a hematopoietic cell line by upregulating c-Jun expression
11. Malignant transformation induced by cytokine genes: A comparison of the abilities of germline and mutated interleukin 3 genes to transform hematopoietic cells by transcriptional and post-transcriptional mechanisms
12. Differential effects of retroviral long terminal repeats on interleukin-3 gene expression and autocrine transformation
13. Growth promoting effects of insulin-like growth factor-1 on hematopoietic cells: Overexpression of introduced IGF-1 receptor abrogates IL-3-dependency of murine factor dependent cells by a ligand-dependent mechanism
14. Characterization of proteins binding specifically to the interleukin 3 (IL-3) mRNA 3′ untranslated region in IL-3-dependent and autocrine transformed cells
15. Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit of the human IL-3 and GM-CSF receptors
16. Cytokine receptors and signal transduction
17. Regulation of the interleukin-3 (IL-3) receptor by IL-3 in the fetal liver-derived FL5.12 cell line
18. Signaling through the hematopoietic cytokine receptors
19. Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors
20. Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cells
21. The CIS/JAB family; novel negative regulators of JAK signaling pathways
22. The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells
23. Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin and Bcr-Abl
24. The signal transduction through Grb2/Ash in hematopoietic cells
25. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells
26. Phosphorylation of Cbl following stimulation with interleukin-3 and its association with Grb2, Fyn and phosphatidylinositol 3-kinase
27. The role of serine/threonine phosphorylation in hematopoietic cytokine receptor signal transduction
28. Activation of the mitogen-activated protein kinase pathway in Triton X-100 disrupted NIH-3T3 cells by p21 ras and in vitro by plasma membranes from NIH-3T3 cells
29. Expression, purification and characterization of recombinant mitogen-activated protein kinase kinases
30. Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro
31. Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation
32. Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway
33. Activation of Raf-1 by interferon gamma and oncostatin M requires expression of the Stat 1 transcription factor
34. Interferon gamma activation of Raf-1 is Jak 1-dependent and p21 ras-independent
35. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: Modulation of megakaryocytic differentiation of K562 cells
36. PMA-induced phenotypic changes in K562 cells: MAPK-dependent and -independent events
37. The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio-and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity
38. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
39. Transformation of mammalian cells by constitutively active MAP kinase kinase
40. Biochemical and biological analysis of MEK1 phosphorylation site mutants
41. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts
42. Transcriptional regulation by MAP kinases
43. Apoptosis meets signal transduction: Elimination of a Bad influence
44. L and Bcl-2, displaces Bax and promotes cell death
45. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase
46. Bcl-2 targets the protein kinase Raf-1 to mitochondria
47. Bcl-2 interacting protein, Bag-1, binds to and activates the kinase Raf-1
48. Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 14-3-3 not Bcl-xL
49. Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis
50. Human interleukin-3 receptor modulates Bcl-2 mRNA and protein levels through protein kinase C in TF-1 cells
51. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
52. Bcl-2 phosphorylation required for anti-apoptosis function
53. Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A
54. Overexpression of protein kinase C isoform epsilon, but not delta in human interleukin-3-dependent cells suppresses apoptosis and induces bcl-2 expression
55. v-Raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells
56. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
57. The role of MAP kinase in interleukin-3 stimulation of proliferation
58. A conditionally active form of MEK1 abrogates cytokine dependency in human and mouse hematopoietic cells
59. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1
60. Advanced mammalian gene transfer: High titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
61. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase
62. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH-3T3 cells
63. Complementation of defective colony-stimulating factor 1 signaling and mitogenesis by Raf and v-Src
64. Autocrine growth factor secretion after transformation of human cytokine-dependent cells by viral and cellular oncogenes
65. Induction of cell proliferation in quiescent NIH3T3 cells by oncogenic c-Raf-1